Skip to main content
Log in

Determinants of Daytime Blood Pressure in Relation to Obstructive Sleep Apnea in Men

  • Published:
Lung Aims and scope Submit manuscript

Abstract

This study investigated the roles of different potential pathophysiological mechanisms in the determination of blood pressure in relation to obstructive sleep apnea. The study was designed as a cross-sectional study. Consecutive healthy male subjects who were to undergo polysomnography were recruited. Demographic and anthropometric data were collected. Blood pressure measurements were taken in the evening before sleep and the next morning on waking. Overnight urinary samples for catecholamines and fasting blood for cortisol, insulin, glucose, and lipids were taken. Ninety-four men were analyzed, with a mean age of 43.7 ± 9.3 years and mean apnea–hypopnea index (AHI) of 27.5 ± 26.2 events/h. Sixty-nine patients (73%) had obstructive sleep apnea (AHI ≥ 5). Urinary catecholamines were positively correlated with severity of sleep apnea, independent of obesity. Blood pressure measurements correlated with age, obesity, severity of sleep apnea, and urinary catecholamines. Regression analysis showed that sleep indices and urinary catecholamines were independent determinants of morning systolic and diastolic blood pressure, respectively, while total cholesterol and waist circumference were respective additional factors. Urinary catecholamines and waist circumference were determinants of evening blood pressure, with morning cortisol being an additional determinant for diastolic blood pressure. Obstructive sleep apnea and related sympathetic activity contributed significantly to the determination of daytime blood pressure in overweight middle-aged men without overt cardiometabolic diseases, and other contributing factors include abdominal obesity, total cholesterol, and cortisol levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McNicholas WT, Bonsignore MR, Management Committee of EU COST ACTION B26 (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29:156–178

    Article  PubMed  CAS  Google Scholar 

  2. Fatima H, Kuniyoshi S, Somers VK (2006) Sleep apnea in hypertension—when, how, and why should we treat? Editorial commentary. Hypertension 47:818–819

    Article  Google Scholar 

  3. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239

    Article  PubMed  Google Scholar 

  4. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283:1829–1836

    CAS  Google Scholar 

  5. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384

    Article  PubMed  CAS  Google Scholar 

  6. Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320:479–482

    Article  PubMed  CAS  Google Scholar 

  7. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A (2000) Association of hypertension and sleep-disordered breathing. Arch Intern Med 160:2289–2295

    Article  PubMed  CAS  Google Scholar 

  8. Davies CW, Crosby JH, Mullins RL, Barbour C, Davies RJ, Stradling JR (2000) Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 55:736–740

    Article  PubMed  CAS  Google Scholar 

  9. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J (1997) Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157:1746–1752

    Article  PubMed  CAS  Google Scholar 

  10. Faccenda JF, Mackay TW, Boon NA, Douglas NJ (2001) Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163:344–348

    PubMed  CAS  Google Scholar 

  11. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359:204–210

    Article  PubMed  Google Scholar 

  12. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68–73

    Google Scholar 

  13. Hui DS, To KW, Ko FW, Fok JP, Chan MC, Ngai JC, Tung AH, Ho CW, Tong MW, Szeto CC, Yu CM (2006) Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnea and mild sleepiness. Thorax 61:1083–1090

    Article  PubMed  CAS  Google Scholar 

  14. Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, Lima-Alvarez J, Benitez MA, Almeida-Gonzalez C (2007) Long-term of continuous positive airway pressure on blood pressure in patients with hypertension and sleep apnea. Chest 132:1847–1852

    Article  PubMed  Google Scholar 

  15. Robinson GV, Smith DM, Langford BA, Davis RJ, Stradling JR (2006) Continuous positive airway pressure does not reduce blood pressure in non-sleepy hypertensive obstructive sleep apnoea patients. Eur Respir J 27:1229–1235

    Article  PubMed  CAS  Google Scholar 

  16. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904

    Article  PubMed  CAS  Google Scholar 

  17. Leung RS, Bradley TD (2001) Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164:2147–2165

    PubMed  CAS  Google Scholar 

  18. Fletcher EC (2000) Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol 119:189–197

    Article  PubMed  CAS  Google Scholar 

  19. Pepperell JC, Davies RJ, Stradling JR (2002) Systemic hypertension and obstructive sleep apnoea. Sleep Med Rev 6:157–173

    Article  PubMed  Google Scholar 

  20. Narkiewicz K, Somers VK (2003) Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177:385–390

    Article  PubMed  CAS  Google Scholar 

  21. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, Blood Institute Joint National Committee on Prevention, Detection, Evaluation, Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560–2572

    Article  PubMed  CAS  Google Scholar 

  22. Lohman TG, Roche AF, Martorell R (1988) Anthropometric standardization reference manual. Human Kinetics Books, Champaign, IL, pp 1–10

    Google Scholar 

  23. Rechtschaffen A, Kales A (1968) A manual of standardized terminology techniques and scoring system for sleep stages of human subjects. U.S. Department of Health Education and Welfare, National Institutes of Health Publication No. 204, Bethesda, MD, pp 1–50

    Google Scholar 

  24. American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–789

    Google Scholar 

  25. American Sleep Disorders Association (1992) EEG arousals: scoring rules and examples: ASDA report. Sleep 15:173–184

    Google Scholar 

  26. Chan YP, Siu TS (1988) Simultaneous quantitation of catecholamines and O-methylated metabolites in urine by isocratic ion-pairing high-performance liquid chromatography with amperometric detection. J Chromatogr 459:251–260

    Article  PubMed  CAS  Google Scholar 

  27. Pastoris A, Cerutti L, Sacco R, De Vecchi L, Shaffi A (1995) Automated analysis of urinary catecholamines by high-performance liquid chromatography and on-line sample pretreatment. J Chromatogr B Biomed Appl 664:287–293

    Article  PubMed  CAS  Google Scholar 

  28. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS (2002) Obstructive sleep apnea is independently associated with insulin reistance. Am J Respir Crit Care Med 165:670–676

    PubMed  Google Scholar 

  29. Corona H, Contestable P, Klose J, Lynn S, Synder B (1997) Development of a chemiluminescent cortisol assay for use on the Vitro ECi immunodiagnostic system. Clin Chem 43:S173

    Google Scholar 

  30. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JPH, Calverley PMA (2007) Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 29:720–727

    Article  PubMed  CAS  Google Scholar 

  31. Bazzano LA, Khan Z, Reynolds K, He J (2007) Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50:417–423

    Article  PubMed  CAS  Google Scholar 

  32. Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E, Ryan CF, Fleetham J, Choi P, Ayas NT (2007) Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a metaanalysis of randomized controlled trials. Lung 185:67–72

    Article  PubMed  CAS  Google Scholar 

  33. Loredo JS, Ancoli-Israel S, Dimsdale JE (2001) Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens 14:887–892

    Article  PubMed  CAS  Google Scholar 

  34. Suzuki M, Guilleminault C, Otsuka K, Shiomi T (1996) Blood pressure “dipping” and “non-dipping” in obstructive sleep apnea syndrome patients. Sleep 19:382–387

    PubMed  CAS  Google Scholar 

  35. Portaluppi F, Provini F, Cortelli P, Plazzi G, Bertozzi N, Manfredini R, Fersini C, Lugaresi E (1997) Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 15:1227–1233

    Article  PubMed  CAS  Google Scholar 

  36. Noda A, Yasuma F, Okada T, Yokota M (2000) Influence of movement arousal on circadian rhythm of blood pressure in obstructive sleep apnea syndrome. J Hypertens 18:539–544

    Article  PubMed  CAS  Google Scholar 

  37. Stradling JR, Partlett J, Davies RJ, Siegwart D, Tarassenko L (1996) Effect of short term graded withdrawal of nasal continuous positive airway pressure on systemic blood pressure in patients with obstructive sleep apnoea. Blood Press 5:234–240

    Article  PubMed  CAS  Google Scholar 

  38. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741

    Article  PubMed  Google Scholar 

  39. Lam JC, Lam B, Lam CL, Fong D, Wang JK, Tse HF (2006) Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir Med 100:980–987

    Article  PubMed  Google Scholar 

  40. Antic V, Dulloo A, Montani JP (2003) Multiple mechanisms involved in obesity-induced hypertension. Heart Lung Circ 12:84–93

    Article  PubMed  Google Scholar 

  41. Fossum E, Hoieggen A, Reims HM, Moan A, Rostrup M, Eide I, Kjeldsen SE (2004) High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men. Blood Press 13:89–94

    Article  PubMed  Google Scholar 

  42. Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J (1995) The effect of sleep apnea on plasma and urinary catecholamines. Sleep 18:377–381

    PubMed  CAS  Google Scholar 

  43. Elmasry A, Lindberg E, Hedner J, Janson C, Boman G (2002) Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study. Eur Respir J 19:511–517

    Article  PubMed  CAS  Google Scholar 

  44. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR (1993) Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 103:722–727

    Article  PubMed  CAS  Google Scholar 

  45. Rosmond R, Dallman MF, Bjorntorp P (1998) Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83:1853–1859

    Article  PubMed  CAS  Google Scholar 

  46. Imai Y, Abe K, Sasaki S, Minami N, Munakata M, Nihei M, Sekino H, Yoshinaga K (1989) Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations. J Hypertens 7:113–120

    PubMed  CAS  Google Scholar 

  47. Takahashi H, Takeda K, Ashizawa H, Inoue A, Yoneda S, Yoshimura M, Ijichi H (1983) Centrally induced cardiovascular and sympathetic responses to hydrocortisone in rats. Am J Physiol 245:H1013–H1018

    PubMed  CAS  Google Scholar 

  48. Kalsner S (1969) Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta. Circ Res 24:383–395

    PubMed  CAS  Google Scholar 

  49. Parlapiano C, Borgia MC, Minni A, Alessandri N, Basal I, Saponara M (2005) Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients. Endocr Res 31:371–374

    Article  PubMed  CAS  Google Scholar 

  50. Dadoun F, Darmon P, Achard V, Boullu-Ciocca S, Philip-Joet F, Alessi MC, Rey M, Grino M, Dutour A (2007) Effect of sleep apnoea syndrome on the circadian profile of cortisol in obese men. Am J Physiol Endocrinol Metab 293:E466–E474

    Article  PubMed  CAS  Google Scholar 

  51. De Bacquer D, De Backer G (2006) The prevalence of concomitant hypertension and hypercholesterolaemia in the general population. Int J Cardiol 110:217–223

    Article  PubMed  Google Scholar 

  52. Grassi G, Facchini A, Trevano FQ, Dell’Oro R, Arenare F, Tana F, Bolla G, Monzani A, Robuschi M, Mancia G (2005) Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 46:321–325

    Article  PubMed  CAS  Google Scholar 

  53. Wolk R, Shamsuzzaman AS, Somers VK (2003) Obesity, sleep apnea, and hypertension. Hypertension 42:1067–1074

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by the Lee Wing Tat Cardiorespiratory Research Fund, Department of Medicine, University of Hong Kong.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mary S. M. Ip.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lam, J.C.M., Yan, C.S.W., Lai, A.Y.K. et al. Determinants of Daytime Blood Pressure in Relation to Obstructive Sleep Apnea in Men. Lung 187, 291–298 (2009). https://doi.org/10.1007/s00408-009-9161-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-009-9161-7

Keywords

Navigation